Rockefeller Capital Management L.P. Haemonetics Corp Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$73.85 - $86.14 $960 - $1,119	13 New	13 $1,000
Q2 2022 Aug 12, 2022	BUY	$49.27 - $66.08 $16,406 - $22,004	333 Added 628.3%	386 $25,000
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $131 - $189	3 Added 6.0%	53 $3,000
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $148 - $223	-3 Reduced 5.66%	50 $2,000
Q3 2021 Nov 12, 2021	BUY	$57.6 - $70.59 $1,728 - $2,117	30 Added 130.43%	53 $3,000
Q2 2021 Aug 10, 2021	SELL	$51.81 - $118.56 $362 - $829	-7 Reduced 23.33%	23 $1,000
Q1 2021 May 11, 2021	SELL	$111.01 - $139.48 $1,332 - $1,673	-12 Reduced 28.57%	30 $3,000
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $3,727 - $5,037	42 New	42 $4,000
Q4 2019 Feb 07, 2020	SELL	$114.37 - $129.46 $8,005 - $9,062	-70 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$81.74 - $120.34 $4,086 - $6,017	50 Added 250.0%	70 $8,000
Q1 2019 May 10, 2019	BUY	$83.25 - $102.12 $1,665 - $2,042	20 New	20 $2,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.